» Articles » PMID: 37295965

Socioeconomic, Lifestyle and Biological Determinants of Cervical Screening Coverage: Lolland-Falster Health Study, Denmark

Overview
Specialty Public Health
Date 2023 Jun 9
PMID 37295965
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer is preventable. Screening is important for early detection. However, even in high-income countries, coverage is sub-optimal. We identified socioeconomic, lifestyle and biological determinants of cervical screening coverage.

Methods: In Denmark, women aged 23-64 are free of charge personally invited to screening. All cervical cell samples are registered centrally in the Patobank. We linked data from the Lolland-Falster Health Study (LOFUS) with Patobank data. LOFUS was a population-based health survey undertaken in 2016-2020. With logistic regression, coverage defined as ≥1 cervical sample registered within a 6-year period from 2015 to 2020 was compared across levels of risk factors expressed as adjusted odds ratios (aOR) with 95% confidence intervals (CI).

Results: Among 13 406 women of screening aged 23-64 and invited to LOFUS, 72% had ≥1 cervical sample registered. Non-participation in LOFUS was a strong predictor of low coverage; aOR 0.32; 95% CI 0.31-0.36. Among LOFUS participants, education was a strong predictor of coverage in univariate analysis, OR 0.58; 95% CI 0.48-0.71, but this association disappeared in multi-variate analysis, aOR 0.86; 95% CI 0.66-1.10. In multi-variate analysis, predictors of low coverage were high age, living without a partner, retired, current smoker, poor self-rated health, elevated blood pressure and elevated glycated haemoglobin.

Conclusions: Women with low cervical screening coverage had limited contact to healthcare, exemplified by non-participation in LOFUS, and pertinent health and social problems, exemplified by elevated blood pressure and glycated haemoglobin, poor self-rated health, and retirement already in screening age. Structural changes in screening are needed to reach non-screened women.

Citing Articles

Non-participation in breast screening in Denmark: Sociodemographic determinants.

von Euler-Chelpin M, Napolitano G, Lynge E, Borstrom S, Vejborg I BMC Public Health. 2024; 24(1):2024.

PMID: 39075424 PMC: 11285456. DOI: 10.1186/s12889-024-19547-x.

References
1.
Hansen B, Hukkelberg S, Haldorsen T, Eriksen T, Skare G, Nygard M . Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. BMC Public Health. 2011; 11:264. PMC: 3111379. DOI: 10.1186/1471-2458-11-264. View

2.
Jepsen R, Egholm C, Brodersen J, Simonsen E, Grarup J, Cyron A . Lolland-Falster Health Study: Study protocol for a household-based prospective cohort study. Scand J Public Health. 2018; 48(4):382-390. PMC: 7263040. DOI: 10.1177/1403494818799613. View

3.
Musa J, Achenbach C, ODwyer L, Evans C, McHugh M, Hou L . Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017; 12(9):e0183924. PMC: 5584806. DOI: 10.1371/journal.pone.0183924. View

4.
Eaker S, Adami H, Granath F, Wilander E, Sparen P . A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13(3):346-54. View

5.
Tranberg M, Larsen M, Mikkelsen E, Svanholm H, Andersen B . Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. BMC Public Health. 2015; 15:681. PMC: 4508820. DOI: 10.1186/s12889-015-2039-0. View